Yinhu Qingwen Granula for the Treatment of Severe CoVID-19

Clinical trial NCT04310865 · SUSPENDED

Trial details

NCT number: NCT04310865
Sponsor: Zhong Wang
Status: SUSPENDED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

COVID-19 Severe Pneumonia Chinese Medicine

Start date: 2021-11-01
Primary completion: 2022-12-01
Enrollment: 116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.